News
UCB and Biogen say their first phase 3 trial of systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, with a second planned.
Find the latest Super League Enterprise, Inc. (SLE) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results